title: Methylphenidate for attention-deficit/hyperactivity disorder: Too much of a good thing?
authors.affiliation: Department of Psychological Medicine, University of Otago - Christchurch, Christchurch, New Zealand roger.mulder@otago.ac.nz.
authors.forename: Roger
authors.initials: R
authors.lastname: Mulder
authors.affiliation: Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Philip
authors.initials: P
authors.lastname: Hazell
authors.affiliation: University of Canterbury, Christchurch, New Zealand.
authors.forename: Julia J
authors.initials: JJ
authors.lastname: Rucklidge
authors.affiliation: Discipline of Psychiatry, Kolling Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, St Leonards, NSW, Australia.
authors.forename: Gin S
authors.initials: GS
authors.lastname: Malhi
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate